Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: a Markov analysis. [electronic resource]
Producer: 20060713Description: 369-76 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Aged, 80 and over
- Anemia -- chemically induced
- Antineoplastic Agents -- adverse effects
- Blood Transfusion -- economics
- Costs and Cost Analysis
- Darbepoetin alfa
- Drug Administration Schedule
- Erythropoietin -- administration & dosage
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Markov Chains
- Middle Aged
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.